Evidence map›Paper›PMID 37657448›Full record

ArticleStem cell reports2023

Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model.

Hirotaka Watanabe, Rei Murakami, Kazuya Tsumagari, Satoru Morimoto, Tadafumi Hashimoto, Kent Imaizumi, Iki Sonn, Kaoru Yamada, Yuko Saito, Shigeo Murayama and 2 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Inhibitory Roles ofThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Hirotaka WatanabeDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan. Electronic address: hwatanabe@keio.jp.
Rei MurakamiDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan; Research Fellow of Japan Society for the Promotion of Science (JSPS), Tokyo 102-0083, Japan.
Kazuya TsumagariCenter for Integrated Medical Research, Keio University School of Medicine, Tokyo 160-8582, Japan.
Satoru MorimotoDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Tadafumi HashimotoDepartment of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Kent ImaizumiDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Iki SonnDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan; Research Fellow of Japan Society for the Promotion of Science (JSPS), Tokyo 102-0083, Japan.
Kaoru YamadaDepartment of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Yuko SaitoDepartment of Neuropathology (the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 173-0015, Japan.
Shigeo MurayamaDepartment of Neuropathology (the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 173-0015, Japan; Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University, Osaka 565-0871, Japan.
Takeshi IwatsuboDepartment of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan. Electronic address: hidokano@keio.jp.
Keio University · JPThe University of Tokyo · JPNational Center of Neurology and Psychiatry · JPTokyo Metropolitan Geriatric Hospital · JPTokyo Metropolitan Neurological Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The APOE4 genotype is the strongest risk factor for the pathogenesis of sporadic Alzheimer's disease (AD), but the detailed molecular mechanism of APOE4-mediated synaptic impairment remains to be determined. In this study, we generated a human astrocyte model carrying the APOE3 or APOE4 genotype using human induced pluripotent stem cells (iPSCs) in which isogenic APOE4 iPSCs were genome edited from healthy control APOE3 iPSCs. Next, we demonstrated that the astrocytic APOE4 genotype negatively affects dendritic spine dynamics in a co-culture system with primary neurons. Transcriptome analysis revealed an increase of EDIL3, an extracellular matrix glycoprotein, in human APOE4 astrocytes, which could underlie dendritic spine reduction in neuronal cultures. Accordingly, postmortem AD brains carrying the APOE4 allele have elevated levels of EDIL3 protein deposits within amyloid plaques. Together, these results demonstrate the novel deleterious effect of human APOE4 astrocytes on synaptic architecture and may help to elucidate the mechanism of APOE4-linked AD pathogenesis.

Indexed as

Induced Pluripotent Stem CellsPluripotent Stem CellsApolipoprotein E3Apolipoprotein E4Apolipoproteins EAstrocytesCalcium-Binding ProteinsCell Adhesion MoleculesGenotypeHumansApoE protein, humanApolipoprotein E3Apolipoprotein E4Apolipoproteins ECalcium-Binding ProteinsCell Adhesion MoleculesEDIL3 protein, humanAlzheimer’s diseaseAPOEapolipoprotein Eastrocyteinduced pluripotent stem cellsiPSCs

Identifiers

PMID37657448
PMCPMC10545487
OpenAlexW4386334009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.